COLUMBIA, Md., January 27, 2024
Xcision to feature GammaPod™ at Arab Health 2024
GammaPod provides new treatment options for breast cancer patients
Xcision Medical Systems, LLC, a medical technology company developing advanced stereotactic radiotherapy solutions to improve cancer care, will demonstrate GammaPod at Arab Health, January 29-February 1, 2024. GammaPod is the world’s first stereotactic radiotherapy system optimized for treating early stage breast cancer.
With World Cancer Day approaching on February 4, it’s important to note that breast cancer is the most diagnosed cancer worldwide, according to the Union for International Cancer Control. This year’s theme for World Cancer Day, “Close the Care Gap” echoes Xcision’s mission: to address the growing global demand for higher quality, more efficient and cost-effective cancer care that improves patient satisfaction and convenience.
As Michelle Crawley, President of Xcision Medical Systems, notes, “there are many places, even in the United States, where people have to go over 500 miles to get treated with radiation therapy. GammaPod is built to change the way providers manage breast cancer at a time when health care systems demand greater value. By offering a treatment option with fewer sessions, GammaPod provides high quality care while achieving high levels of patient satisfaction.”
GammaPod shortens the treatment course to 5 days or less vs 4-6 weeks with conventional radiation therapy.
By shortening the course of treatment from 4-6 weeks of conventional radiation to just 5 days or less, Xcision’s GammaPod makes breast cancer care more accessible. The shorter course of treatment minimizes disruption to the patients’ lives and reduces the cost of travel, even in local commutes. Patients can get back to their normal routines in a fraction of the time.
Visit Xcision at Arab Health at the Dubai World Trade Centre from January 29-February 1, 2024.
For further information, please contact:
Michelle Crawley, President
Xcision Medical Systems
info@xcision.com
443-681-7500
About Xcision Medical Systems
Xcision Medical Systems, LLC is a medical technology company developing advanced stereotactic radiotherapy solutions with the potential to dramatically raise the quality of treatments and improve the lives of patients and their loved ones. The company’s solutions are designed to extend the benefits of radiation oncology to more patients and enable noninvasive treatments that allow patients to return to living fuller lives more quickly and less painfully after receiving a cancer diagnosis.
GammaPod has received 510(k) clearance from the FDA and is CE marked in Europe.
To learn more about GammaPod and Xcision Medical Systems, visit: https://www.xcision.com